US expected to increase biodefence spending under Trump, says vaccine maker Bavarian Nordic

Reuters11-15

By Jacob Gronholt-Pedersen COPENHAGEN (Reuters) -Vaccine maker Bavarian Nordic expects the incoming Trump administration to boost biodefence funding despite the nomination of Robert F. Kennedy Jr., ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2483132231?lang=en_US&edition=fundamental","thumbnail":"https://s.yimg.com/uu/api/res/1.2/Ied96a5JzM9__yAsTHeGIg--~B/aD01MzQ7dz04MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/reuters-finance.com/3e1439e0d9131fd2336893897b73adb9","is_english":true,"pubTime":"2024-11-15 18:40","share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","id":"2483132231","market":"us","top_or_hot":-1,"title":"US expected to increase biodefence spending under Trump, says vaccine maker Bavarian Nordic","media":"Reuters","content":"<div>\n<p>By Jacob Gronholt-Pedersen \n COPENHAGEN (Reuters) -Vaccine maker Bavarian Nordic expects the incoming Trump administration to boost biodefence funding despite the nomination of Robert F. Kennedy Jr., ...</p>\n\n<a href=\"https://finance.yahoo.com/news/us-expected-increase-biodefence-spending-104034434.html\">Source Link</a>\n\n</div>\n","source":"yahoofinance","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>US expected to increase biodefence spending under Trump, says vaccine maker Bavarian Nordic</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nUS expected to increase biodefence spending under Trump, says vaccine maker Bavarian Nordic\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-11-15 18:40 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/us-expected-increase-biodefence-spending-104034434.html><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>By Jacob Gronholt-Pedersen \n COPENHAGEN (Reuters) -Vaccine maker Bavarian Nordic expects the incoming Trump administration to boost biodefence funding despite the nomination of Robert F. Kennedy Jr., ...</p>\n\n<a href=\"https://finance.yahoo.com/news/us-expected-increase-biodefence-spending-104034434.html\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4139","symbol_name":"生物科技","start_time":0,"source_url":"https://finance.yahoo.com/news/us-expected-increase-biodefence-spending-104034434.html","article_id":"2483132231","we_media_id":null,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/Ied96a5JzM9__yAsTHeGIg--~B/aD01MzQ7dz04MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/reuters-finance.com/3e1439e0d9131fd2336893897b73adb9"],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2483132231","pubTimestamp":1731667234,"columns":[],"sourceInfo":{"source_id":"yahoofinance","name":"雅虎金融"},"weMediaInfo":null,"summary":"COPENHAGEN  -Vaccine maker Bavarian Nordic expects the incoming Trump administration to boost biodefence funding despite the nomination of Robert F. Kennedy Jr., a vaccine sceptic, as health secretary, the company's CEO said on Friday.Shares in European vaccine makers fell on Friday after U.S. President-elect Donald Trump selected Kennedy, who has previously spread misinformation on vaccines, to lead the top health agency.\"Vaccine scepticism was part of Trump's first administration,\" Bavarian Nordic CEO Paul Chaplin told Reuters in an interview.\"The only thing I've ever seen with a Republican administration is that the biodefence business and funding goes up,\" said Chaplin.Chaplin said he is a bit more concerned how Kennedy will impact the spread of vaccine scepticism and sales for general vaccine programs, which include an anti-rabies treatment.\"It doesn't help when you've got a health secretary who's sceptical of vaccines in convincing the public to take vaccines,\" Chaplin said.Share","collect":0,"end_time":0,"defaultTopTitle":"yahoo.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4139":"生物科技","BVNKF":"Bavarian Nordic A/S","BVNRY":"Bavarian Nordic A/S"},"translate_title":"疫苗制造商巴伐利亚北欧公司表示，美国预计将在特朗普的领导下增加生物防御支出","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"BVNKF":0.9,"BVNRY":0.9},"content_text":"By Jacob Gronholt-Pedersen \n COPENHAGEN (Reuters) -Vaccine maker Bavarian Nordic expects the incoming Trump administration to boost biodefence funding despite the nomination of Robert F. Kennedy Jr., a vaccine sceptic, as health secretary, the company's CEO said on Friday. \n Shares in European vaccine makers fell on Friday after U.S. President-elect Donald Trump selected Kennedy, who has previously spread misinformation on vaccines, to lead the top health agency. \n \"Vaccine scepticism was part of Trump's first administration,\" Bavarian Nordic CEO Paul Chaplin told Reuters in an interview. \n \"When I look back at his first administration, it was some of the most successful years in terms of the public preparedness business with the U.S. government,\" he said. \n Biodefence is preparing for and responding to potential biological threats, from pandemics to potential biological warfare. \n \"The only thing I've ever seen with a Republican administration is that the biodefence business and funding goes up,\" said Chaplin. \n Bavarian Nordic is providing the U.S. government with a freeze-dried variant of its smallpox vaccine as part of America's smallpox preparedness strategy. Its current contract with the U.S. government expires in 2027, Chaplin said. \n The company's smallpox vaccine is also approved for mpox in certain countries. \n Chaplin said he is a bit more concerned how Kennedy will impact the spread of vaccine scepticism and sales for general vaccine programs, which include an anti-rabies treatment. \n \"It doesn't help when you've got a health secretary who's sceptical of vaccines in convincing the public to take vaccines,\" Chaplin said. \n Shares in Bavarian fell more than 16%, hurt by third-quarter results. Analysts at Sydbank and Kempen told Reuters that the nomination of Kennedy also weighed on the stock. \n (Reporting by Jacob Gronholt-PedersenEditing by Stine Jacobsen and Angus MacSwan)","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2483132231"}